We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

First-of-Its-Kind Lipidomics Excellence Award Acknowledges Forward-thinking in a Rapidly Growing Field
Industry Insight

Technology Networks recently visited Dresden, Germany, for Lipotype's Lipid Excellence Award press talk, where we gained insights into the past, present and future of lipidomics research.

Read More

Exploring the Fourth Dimension of Proteome Analysis
Industry Insight

Recent developments in MS technology have enabled a fourth dimension of analysis: ion mobility separation. The term "4D proteomics" has been created to describe analysis that incorporates all four dimensions. We interviewed two researchers at the forefront of the proteomics field to learn more about how 4D proteomics approaches are enhancing their research.


Read More

Talking Clinical Proteomics With Dr Roman Fischer
Industry Insight

Technology Networks spoke with Dr Roman Fischer to learn more about the challenges researchers face in the field of clinical proteomics, and how 4D proteomics workflows are enhancing his laboratory's work.

Read More

Digital Technology Enhancing Lateral Flow Diagnostics
Industry Insight

Digitization is a trend threading many disciplines, and lateral flow is no exception. Here, we share insights from Dave Taylor, co-founder and chief operating officer of Bond Digital Health, a UK-based life sciences company that develops app and cloud technology solutions for lateral flow diagnostics.

Read More

Harnessing the Power of Proteins To Unlock Cell and Gene Therapies
Industry Insight

We recently spoke with Paul Wotton, Ph.D., CEO at Obsidian Therapeutics, to gain his insights on the genetically engineered cell-therapy research area, and to learn how Obsidian Therapeutics' cytoDRiVE platform can increases the specificity and safety of such therapies.

Read More

First-of-its-Kind Cyclic IMS Promises Unlimited Experimental Opportunities
Industry Insight

Ion mobility spectrometry (IMS) coupled to mass spectrometry (MS) has witnessed significant growth over the last two decades. To better understand IMS, the benefits this technology provides, and exactly what Waters' new SELECT SERIES CyclicTM IMS offers, we spoke to Emma Marsden-Edwards.

Read More

Size Matters: Diffusion Technique Sorts Out Pathological Proteins
Industry Insight

Proteinopathies are diseases that feature misfolded proteins. In the brain, proteinopathies are rife, but research techniques are facing up to the challenge of studying these diseases. We talked to the University of Cambridge’s Tom Scheidt, whose research uses an innovative technique called diffusional sizing to better understand proteins.

Read More

Waters’ Highly Flexible SYNAPT XS Offers Freedom of Analytical Choice
Industry Insight

A highly flexible and high-resolution mass spectrometer, the SYNAPT™ XS technology from Waters has been developed with the analytical needs of R&D labs in mind. Joanne Ballantyne tells us more about the development of SYNAPT™ XS and the features to which it lends its versatility.

Read More

Wellness and Illness From a Precision Quantification Perspective
Industry Insight

In this interview, Aaron Hudson, Vice President & General Manager, Global Marketing & Strategy at SCIEX, discusses why precision quantification, specifically quantitative mass spectrometry (MS), is the best approach for measuring the transition from "wellness" to illness.

Read More

BioAccord LC-MS: Making Mass Spectrometry Available to the Masses
Industry Insight

Earlier in 2019, Waters Corporation announced their BioAccord LC-MS System for biopharmaceutical analysis. We spoke with John Gebler, PhD, Director of Strategic Business Development at Waters Corporation to learn more about the BioAccord System and its applications.

Read More

 
Advertisement